12-Jun-2026
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
Globe Newswire (Wed, 3-Jun 8:00 AM ET)
Integer Holdings Corporation Reports First Quarter 2026 Results
Globe Newswire (Thu, 30-Apr 8:00 AM ET)
Integer Announces Strategic Review to Maximize Stockholder Value
Globe Newswire (Thu, 30-Apr 8:00 AM ET)
Integer to Participate in Bank of America Healthcare Conference on May 12
Globe Newswire (Wed, 29-Apr 8:00 AM ET)
Kuehn Law Encourages Investors of Integer Holdings Corporation to Contact Law Firm
Globe Newswire (Wed, 22-Apr 9:38 AM ET)
Globe Newswire (Tue, 21-Apr 8:44 AM ET)
Integer Announces Board Leadership Transition
Globe Newswire (Mon, 6-Apr 5:00 PM ET)
Integer Announces Conference Call to Discuss First Quarter 2026 Results
Globe Newswire (Thu, 2-Apr 8:00 AM ET)
Globe Newswire (Wed, 25-Mar 8:23 AM ET)
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
Integer Holdings trades on the NYSE stock market under the symbol ITGR.
As of June 12, 2026, ITGR stock price declined to $90.98 with 208,093 million shares trading.
ITGR has a beta of -0.03, meaning it tends to be less sensitive to market movements. ITGR has a correlation of 0.00 to the broad based SPY ETF.
ITGR has a market cap of $3.10 billion. This is considered a Mid Cap stock.
Last quarter Integer Holdings reported $440 million in Revenue and $1.20 earnings per share. This beat revenue expectation by $13 million and exceeded earnings estimates by $.01.
In the last 3 years, ITGR traded as high as $146.36 and as low as $62.00.
The top ETF exchange traded funds that ITGR belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
ITGR has underperformed the market in the last year with a return of -23.4%, while the SPY ETF gained +24.1%. In the last 3 month period, ITGR fell short of the market, returning +9.2%, while SPY returned +11.6%. However, in the most recent 2 weeks ITGR has outperformed the stock market by returning +1.8%, while SPY returned -1.9%.
ITGR support price is $90.57 and resistance is $93.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ITGR shares will trade within this expected range on the day.